<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>PR.com Press Releases: Blue Sky Biotech News</title>
		<link>https://www.PR.com/</link>
		<description>Latest news releases from PR.com for Blue Sky Biotech.</description>
		<lastBuildDate>Sat, 08 Aug 2026 02:48:45 -0400</lastBuildDate>
		<copyright>&#169; 2026 PR.com</copyright>
		<ttl>60</ttl>
		<language>en-us</language>
		<image>
			<url>https://www.PR.com/images/logo_white.jpg</url>
			<title>PR.com Press Releases: Blue Sky Biotech News</title>
			<link>https://www.PR.com/</link>
			<width>68</width>
			<height>69</height>
			<description>PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles.</description>
		</image>
		<atom:link href="https://www.pr.com/rss/press-releases-2/117390.xml" rel="self" type="application/rss+xml" />
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/242474</guid>
			<title>BIOCIUS Life Sciences and BlueSky Biotech Extend Partnership,  Provide Validated Enzymes Fully&amp;#8208;Validated SIRT1 Enhances Drug Discovery Investigation</title>
			<pubDate>Fri, 18 Jun 2010 03:00:00 -0400</pubDate>
			<description>BIOCIUS Life Sciences Inc., developers of the RapidFire&#174; highthroughputmass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry&#8217;s only Sirtuin (SIRT, silent mating type information regulation homolog) enzyme preparations fully validated in a label&#8208;free functional assay. This collaboration builds on an existing [PR.com]</description>
			<link>https://www.pr.com/press-release/242474</link>
			<dc:creator>Blue Sky Biotech</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/207364</guid>
			<title>Blue Sky Biotech and Protein Attachment Technologies Announce Global Exclusive Licensing Agreement</title>
			<pubDate>Sun, 24 Jan 2010 03:00:00 -0500</pubDate>
			<description>Blue Sky Biotech, Inc. (Blue Sky) and Protein Attachment Technologies, LLC (PA Tech) announced today that they have entered into a global, exclusive license agreement covering PA Tech’s proprietary Template Directed Assembly (TDA™) technology for use in High-Throughput Screening [HTS] of drug candidates against membrane-associated protein targets. [PR.com]</description>
			<link>https://www.pr.com/press-release/207364</link>
			<dc:creator>Blue Sky Biotech</dc:creator>
		</item>
	</channel>
</rss>